Given that 80% of all infections are transmitted by hands[1], regular handwashing with soap is widely seen as one of the most effective ways to prevent the spread of germs and bacteria -- and avoid infections. The practice could reduce the number of people catching colds by 45%[2], according to estimates.
"By implementing an effective hand hygiene programme, companies can go a long way towards avoiding the negative consequences of cold and flu infections, such as decreased productivity and low staff morale, as well as the financial burden," said Paul Jakeway, Deb's Marketing Director.
Sick leave due to colds is currently estimated to cost UK businesses £1.3 billion each year[3].
Deb offers skin care solutions that have been designed to help employees integrate hand hygiene into their working day with as much ease as possible -- from regular handwashing with soap to the use of hand sanitisers where access to running water is inconvenient.
Deb's foam soap solutions require 36% less product for an effective hand wash compared with traditional liquid or lotion soaps. This makes them a cost effective choice, especially in environments where handwashing needs to be frequent if infections are to be avoided.
The highly effective formula of Deb's hand sanitisers kills 99.999% of common germs. It has been specifically designed to provide a high level of hand hygiene even in the most sensitive environments.
BioCote silver ion technology has been incorporated into the full range of Deb's built-to-last dispensers. This effectively reduces bacteria, mould and fungi on the surface. The equipment can be fully customised, allowing companies to feature their own branding on the equipment, if they wish to do so.
Deb also provides supporting materials to help health and safety professionals educate and train employees about the importance of regular hand hygiene and what they can do to prevent colds and the flu this autumn.
[1] Source: US Centers for Disease Control and Prevention
[2] American Journal of Preventive Medicine
[3] Source: Royal Pharmaceutical Society, 2007